Insmed to Host Fourth Quarter and Full-Year 2009 Conference Call
03 Mars 2010 - 2:00PM
PR Newswire (US)
RICHMOND, Va., March 3 /PRNewswire-FirstCall/ -- Insmed Inc. , a
biopharmaceutical company, today announced that it will host a
conference call on Monday, March 15th, at 8:30 AM ET, to discuss
its financial results for the fourth quarter and year-end 2009.
Insmed intends to issue its quarterly financial results press
release before the market opens on March 15th. To participate in
the live conference call, please dial 866-543-6411 (U.S. callers)
or 617-213-8900 (international), and provide passcode 41745811. A
live webcast of the call will also be available at
http://phx.corporate-ir.net/playerlink.zhtml?c=122332&s=wm&e=2782413.
Please allow extra time prior to the webcast to register, download
and install any necessary audio software. The webcast will be
archived for 30 days, and a telephone replay of the call will be
available for seven days, beginning at 11:30 AM ET on March 15th at
888-286-8010 (U.S. callers) or 617-801-6888 (international), using
passcode 80401187. About Insmed Insmed Inc. is a biopharmaceutical
company with unique protein development experience and a
proprietary protein platform aimed at niche markets with unmet
medical needs. For more information, please visit
http://www.insmed.com/. Forward-Looking Statements This release
contains forward-looking statements which are made pursuant to
provisions of Section 21E of the Securities Exchange Act of 1934.
Investors are cautioned that such statements in this release,
including statements relating to business strategies, plans and
objectives of management and our strategic review process,
constitute forward-looking statements which involve risks and
uncertainties that could cause actual results to differ materially
from those anticipated by the forward-looking statements. The risks
and uncertainties include, without limitation, we may be
unsuccessful in identifying or reaching agreement with acquisition
or merger candidates, our expenses may be higher than anticipated
and other risks and challenges detailed in our filings with the
U.S. Securities and Exchange Commission, including our Annual
Report on Form 10-K for the year ended December 31, 2008. Readers
are cautioned not to place undue reliance on any forward-looking
statements which speak only as of the date of this release. We
undertake no obligation to publicly release the results of any
revisions to these forward-looking statements that may be made to
reflect events or circumstances that occur after the date of this
release or to reflect the occurrence of unanticipated events.
Investor Relations Contact: Brian Ritchie - FD 212-850-5683
brian.ritchie@fd.com Media Contact: Irma Gomez-Dib - FD
212-850-5761 Irma.gomez-dib@fd.com DATASOURCE: Insmed Incorporated
CONTACT: Investor Relations, Brian Ritchie,
+1-212-850-5683,brian.ritchie@fd.com, or Media, Irma Gomez-Dib,
+1-212-850-5761,Irma.gomez-dib@fd.com, both of FD, for Insmed Inc.
Web Site: http://www.insmed.com/
Copyright
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Insmed (NASDAQ:INSM)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024